Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing carboplatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |
Carboplatin poisoning |
Causative agent |
True |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |
Accidental carboplatin poisoning |
Causative agent |
False |
Carboplatin (substance) |
Inferred relationship |
Some |
|
Intentional carboplatin poisoning |
Causative agent |
False |
Carboplatin (substance) |
Inferred relationship |
Some |
|
forgiftning med carboplatin, uvist med hvilken hensigt |
Causative agent |
False |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |
Carboplatin adverse reaction |
Causative agent |
True |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |
Allergy to carboplatin (finding) |
Causative agent |
False |
Carboplatin (substance) |
Inferred relationship |
Some |
|
Carboplatin overdose |
Causative agent |
True |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |
Accidental carboplatin overdose |
Causative agent |
True |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |
Intentional carboplatin overdose |
Causative agent |
True |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |
overdosis af carboplatin, uvist med hvilken hensigt |
Causative agent |
False |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |
carboplatin 10 mg/ml infusionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carboplatin (substance) |
Inferred relationship |
Some |
|
carboplatin 10 mg/ml infusionsvæske, opløsning, hætteglas a 45 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carboplatin (substance) |
Inferred relationship |
Some |
|
carboplatin 10 mg/ml infusionsvæske, opløsning, hætteglas a 15 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carboplatin (substance) |
Inferred relationship |
Some |
|
carboplatin 10 mg/ml infusionsvæske, opløsning, hætteglas a 180 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carboplatin (substance) |
Inferred relationship |
Some |
|
carboplatin 10 mg/ml infusionsvæske, opløsning, hætteglas a 90 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carboplatin (substance) |
Inferred relationship |
Some |
|
carboplatin 50 mg hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carboplatin (substance) |
Inferred relationship |
Some |
|
carboplatin 150 mg hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carboplatin (substance) |
Inferred relationship |
Some |
|
carboplatin 450 mg hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carboplatin (substance) |
Inferred relationship |
Some |
|
carboplatin 10 mg/ml infusionsvæske, opløsning, hætteglas a 60 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carboplatin (substance) |
Inferred relationship |
Some |
|
Accidental carboplatin poisoning |
Causative agent |
True |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |
Intentional carboplatin poisoning |
Causative agent |
True |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |
Carboplatin desensitization therapy (regime/therapy) |
Using substance (attribute) |
False |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |
Carboplatin desensitization therapy (regime/therapy) |
Using substance (attribute) |
True |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |
Allergy to carboplatin (finding) |
Causative agent |
True |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |
Carboplatin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |
Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) |
Direct substance |
True |
Carboplatin (substance) |
Inferred relationship |
Some |
6 |
Product containing only carboplatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |
Product containing only carboplatin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely carboplatin 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely carboplatin 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carboplatin (substance) |
Inferred relationship |
Some |
1 |